Table 3.
The Discriminatory Power (C-Index) for Recurrence-Free Survival in the Training Cohort and Validation Cohort
| Combinations | Training Cohort | Validation Cohort | ||
|---|---|---|---|---|
| C-Index | 95% CI | C-Index | 95% CI | |
| FIGO, His-type, His-grade, cervical stromal invasion | 0.84 | 0.78–0.90 | 0.76 | 0.63–0.89 |
| ER, PR, p53 | 0.83 | 0.78–0.88 | 0.77 | 0.64–0.90 |
| FIGO, His-type, ER, p53 | 0.88 | 0.84–0.92 | 0.79 | 0.66–0.92 |
Abbreviations: FIGO, International Federation of Gynecology and Obstetrics; His-, histological; ER, estrogen receptor; PR, progesterone receptor.